| Symptom, n (%) | COVID-19 | Health issues after moderate-severe COVID-19 | |
|---|---|---|---|
| Acute phase | Subacute phase | ||
| Hair loss | 54 (55.1) | 59 (60.2) | 55 (56.1) |
| Fatigue | 51 (52.0) | 44 (44.9) | 42 (42.9) |
| Fatigue | 51 (52.0) | 44 (44.9) | 42 (42.9) |
| Dyspnoea | 41 (41.8) | 40 (40.8) | 33 (33.7) |
| Sleep difficulties | 32 (32.7) | 34 (34.7) | 26 (26.5) |
| Memory loss | 19 (19.4) | 21 (21.4) | 20 (20.4) |
| Persistent cough | 15 (15.3) | 14 (14.3) | 12 (12.2) |
| Ageusia | 12 (12.2) | 2 (2.0) | 1 (1.0) |
| Myalgia | 11 (11.2) | 11 (11.2) | 10 (10.2) |
| Muscle weakness | 10 (10.2) | 10 (10.2) | 9 (9.2) |
| Anosmia | 9 (9.2) | 3 (3.1) | 3 (3.1) |
| Joint pain | 8 (8.2) | 8 (8.2) | 8 (8.2) |
| Palpitations | 8 (8.2) | 8 (8.2) | 8 (8.2) |
| Persistent oxygen requirement | 8 (8.2) | 4 (4.1) | 1 (1.0) |
| Persistent sputum | 6 (6.1) | 6 (6.1) | 6 (6.1) |
| Chest pain | 6 (6.1) | 6 (6.1) | 5 (5.1) |
| Anxiety | 6 (6.1) | 5 (5.1) | 4 (4.1) |
| Diarrhoea | 6 (6.1) | 4 (4.1) | 3 (3.1) |
| Sweating | 4 (4.1) | 4 (4.1) | 4 (4.1) |
| Headache | 4 (4.1) | 4 (4.1) | 2 (2.0) |
| Constipation | 4 (4.1) | 4 (4.1) | 0 (0.0) |
| Anorexia | 3 (3.1) | 2 (2.0) | 2 (2.0) |
| Rigor | 3 (3.1) | 2 (2.0) | 2 (2.0) |
| Itchy | 3 (3.1) | 2 (2.0) | 2 (2.0) |
| Dizziness | 2 (2.0) | 3 (3.1) | 1 (1.0) |
| Visual impairment | 2 (2.0) | 2 (2.0) | 0 (0.0) |
| Fever | 2 (2.0) | 0 (0.0) | 0 (0.0) |
| Nausea | 1 (1.0) | 1 (1.0) | 1 (1.0) |
| Bone pain | 1 (1.0) | 1 (1.0) | 1 (1.0) |